We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Home » FDA Warns Abiomed on Unauthorized Heart Pump Marketing
FDA Warns Abiomed on Unauthorized Heart Pump Marketing
June 29, 2011
Shares in Abiomed fell Tuesday after the company received a letter from the FDA accusing the company of marketing one of its Impella heart pumps without marketing clearance. Mass High Tech
